These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37148830)

  • 1. Soluble epoxide hydrolase inhibitor promotes the healing of oral ulcers.
    Li J; Wen Z; Lou Y; Chen J; Gao L; Li X; Wang F
    Clinics (Sao Paulo); 2023; 78():100208. PubMed ID: 37148830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
    Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
    ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats.
    Bukhari IA; Mohamed OY; Mahmood A; Alfadda AA; Almotrefi AA
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(10):3835-3847. PubMed ID: 34109592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.
    Goswami SK; Wan D; Yang J; Trindade da Silva CA; Morisseau C; Kodani SD; Yang GY; Inceoglu B; Hammock BD
    J Pharmacol Exp Ther; 2016 Jun; 357(3):529-36. PubMed ID: 26989141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
    Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
    J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
    Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction.
    Guo Y; Luo F; Zhang X; Chen J; Shen L; Zhu Y; Xu D
    J Cell Mol Med; 2018 Mar; 22(3):1489-1500. PubMed ID: 29265525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Soluble Epoxide Hydrolase in Macrophages Ameliorates the Formation of Foam Cells　- Role of Heme Oxygenase-1.
    Peng H; Tang J; Zhao S; Shen L; Xu D
    Circ J; 2019 Nov; 83(12):2555-2566. PubMed ID: 31666457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
    Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
    Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of soluble epoxide hydrolase offers protection against fructose-induced diabetes and related metabolic complications in rats.
    Shah SA; Mehmood MH; Khan M; Bukhari IA; Alorainey BI; Vohra F
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33475089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
    Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs.
    Froogh G; Kandhi S; Duvvi R; Le Y; Weng Z; Alruwaili N; Ashe JO; Sun D; Huang A
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H985-H993. PubMed ID: 32167781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
    Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
    Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
    Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.
    Shen Y; Peng W; Chen Q; Hammock BD; Liu J; Li D; Yang J; Ding J; Wang X
    Brain Behav Immun; 2019 Oct; 81():535-544. PubMed ID: 31306773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
    Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model.
    Cagli A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
    Drug Dev Res; 2021 Sep; 82(6):815-825. PubMed ID: 33559150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
    Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD
    Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
    Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.